cbdMD, Inc.YCBDNYSE
Loading
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Revenue | 44 | 35 | 24 |
| Gross Profit | 29 | 21 | 13 |
| Operating Income | -20 | -17 | -9 |
| Net Income | -23 | -70 | -23 |
| EBITDA | -17 | -14 | -6 |
| EPS Diluted | -19.16 | -55.80 | -13.32 |
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Cash & Equivalents | 26 | 7 | 2 |
| Total Current Assets | 37 | 16 | 8 |
| Total Assets | 125 | 41 | 16 |
| Total Current Liabilities | 7 | 5 | 5 |
| Total Liabilities | 22 | 9 | 7 |
| Total Equity | 103 | 31 | 9 |
| Total Debt | 6 | 5 | 4 |
| Net Debt | -20 | -2 | 2 |
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Operating Cash Flow | -14 | -15 | -4 |
| Capital Expenditure | -2 | -1 | -0 |
| Free Cash Flow | -16 | -16 | -5 |
| Stock-Based Comp | 3 | 1 | 0 |
| Net Change in Cash | 12 | -20 | -5 |